A multisite study was conducted by Dr Mikey Karram, Director of Fellowship Program on Female Pelvic Medicine and Reconstructive Surgery at the Christ Hospital, Cincinnati, Ohio and Dr Eric Sokol, Associate Professor of Obstetrics and Gynaecology at the Stanford University Medical Centre.
The trial assessed the use of CO2 fractional laser therapy on 30 women with gynaecological health issued due to natural or induced menopause. All of the patients in the trial were treated with Mona Lisa Touch laser therapy.
· Overwhelmingly positive and immediate results
· Highly statistically significant improvement in symptoms after first treatment
· Escalation of progress with each subsequent treatment
Women in the study either experienced natural menopause or induced menopause as a result of hysterectomy or drug-induced suppression of ovarian function (chemotherapy, radiations and anti cancer drugs such as Tamoxifen).
A study was done by Dr Stefano Salvatore, Department of Obstetrics and Gynaecology, Vita-Salute San Raffaele University, to assess the feasibility of fractional CO2 laser in the treatment of 50 women suffering changes in their gynaecological health.
42 patients (84%) showed significant improvement in their physical and mental quality of life scores over baseline and were satisfied with the treatment. Gynaecological symptoms were significantly improved.